ArticleReproductive health2026
Identifying serum amino acid as biomarkers of gestational diabetes mellitus in second-trimester among Chinese pregnant women: a machine learning-based cross-sectional study.
Article in Reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundLevels of plasma branched-chain and aromatic amino acids in pregnancy have been associated with gestational diabetes mellitus (GDM), but the metabolic role of serum amino acid (AA) profiles in its pathogenesis remains insufficiently elucidated.
objectiveThis study evaluated the diagnostic potential of second-trimester serum AA profiles, including Cys, Met, Val, Lys, Cit, Tau, Asp, Ile and Ala, for distinguishing GDM patients from healthy controls.
methodsA total of 189 women with GDM and 189 healthy women at 24-28 weeks of gestation were enrolled in the study, recruited from 2019 to 2022. Serum levels of 21 amino acids were precisely measured using automatic amino acid analyzer. Three machine learning methods were employed to select the most significant variables. Generalized linear models (GLMs) were established to evaluate the association between Serum AAs and GDM.
resultsSerum cysteine (Cys) and lysine (Lys) were inversely associated with GDM risk, whereas methionine (Met) and citrulline (Cit) showed positive associations. Notably, Met demonstrated an inverted U-shaped relationship, with an inflection at 239.9 µmol/L. The adjusted model achieved higher discrimination than the crude model. Sensitivity and subgroup analyses confirmed robust associations for Cys, while associations for Met, Lys, and Cit varied by pre-pregnancy body mass index (BMI).
conclusionsMid-pregnancy serum AAs, particularly Cys, Lys, Met, and Cit, were associated with GDM risk. These findings highlighted the heterogeneity of GDM metabolic signatures and support AAs as potential biomarkers for diagnosis of GDM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.